AAAAAA
Results:
1-15
|
Results: 15
Authors:
Rubin, EH
Veiel, LL
Kinscherf, DA
Morris, JC
Storandt, M
Citation: Eh. Rubin et al., Clinically significant depressive symptoms and very mild to mild dementia of the Alzheimer type, INT J GER P, 16(7), 2001, pp. 694-701
Authors:
Rubin, EH
Citation: Eh. Rubin, The psychopharmacology of schizophrenia, J CLIN PSY, 62(7), 2001, pp. 577-577
Authors:
Goldman, WP
Price, JL
Storandt, M
Grant, EA
McKeel, DW
Rubin, EH
Morris, JC
Citation: Wp. Goldman et al., Absence of cognitive impairment or decline in preclinical Alzheimer's disease, NEUROLOGY, 56(3), 2001, pp. 361-367
Authors:
Desai, SD
Li, TK
Rodriguez-Bauman, A
Rubin, EH
Liu, LF
Citation: Sd. Desai et al., Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells, CANCER RES, 61(15), 2001, pp. 5926-5932
Authors:
Morris, JC
Storandt, M
Miller, JP
McKeel, DW
Price, JL
Rubin, EH
Berg, L
Citation: Jc. Morris et al., Mild cognitive impairment represents early-stage Alzheimer disease, ARCH NEUROL, 58(3), 2001, pp. 397-405
Authors:
Morris, JC
Storandt, M
Miller, JP
McKeel, DW
Price, JL
Rubin, EH
Berg, L
Citation: Jc. Morris et al., Does mild cognitive impairment represent early-stage Alzheimer disease? Reply, ARCH NEUROL, 58(10), 2001, pp. 1706-1706
Authors:
Morrow-Howell, NL
Proctor, EK
Rubin, EH
Li, H
Thompson, S
Citation: Nl. Morrow-howell et al., Service needs of depressed older adults following acute psychiatric care, AGING MENT, 4(4), 2000, pp. 330-338
Authors:
Rubin, EH
Citation: Eh. Rubin, DNA topoisomerase expression in tumors - A novel target for chemotherapy, HUMAN PATH, 31(6), 2000, pp. 631-632
Authors:
Edwards, TK
Saleem, A
Shaman, JA
Dennis, T
Gerigk, C
Oliveros, E
Gartenberg, MR
Rubin, EH
Citation: Tk. Edwards et al., Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I, J BIOL CHEM, 275(46), 2000, pp. 36181-36188
Authors:
Farber, NB
Rubin, EH
Newcomer, JW
Kinscherf, DA
Miller, JP
Morris, JC
Olney, JW
McKeel, DW
Citation: Nb. Farber et al., Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis, ARCH G PSYC, 57(12), 2000, pp. 1165-1173
Authors:
Yager, J
Smith, N
Spitz, D
Thompson, JW
Andersen, A
Lee, T
Park, SK
Elliott, RL
Greenfeld, D
Juthani, NV
Rubin, EH
Skelton, WD
Templeton, B
Strauss, GD
Coyle, B
Burt, V
Dobscha, SK
Kramer, S
Kuldau, J
Lang, J
Levy, B
Citation: J. Yager et al., The Quality of Psychiatric Residency - The assessment of programs and options for distributing psychiatric residents in the service of health care reform, ACAD PSYCHI, 23(2), 1999, pp. 61-70
Authors:
Pond, CD
Li, XG
Rubin, EH
Barrows, LR
Citation: Cd. Pond et al., Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction, ANTI-CANC D, 10(7), 1999, pp. 647-653
Authors:
Haluska, P
Saleem, A
Rasheed, Z
Ahmed, F
Su, EW
Liu, LF
Rubin, EH
Citation: P. Haluska et al., Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein, NUCL ACID R, 27(12), 1999, pp. 2538-2544
Authors:
Ahmed, F
Vyas, V
Cornfield, A
Goodin, S
Ravikumar, TS
Rubin, EH
Gupta, E
Citation: F. Ahmed et al., In vitro activation of irinotecan to SN-38 by human liver and intestine, ANTICANC R, 19(3A), 1999, pp. 2067-2071
Authors:
Rubin, EH
Citation: Eh. Rubin, Handbook of essential psychopharmacology, J CLIN PSY, 59(12), 1998, pp. 691-691
Risultati:
1-15
|